|
2024
|
Invention
|
Method for treating cholangiocarcinoma having pten gene mutation and/or deletion. A method for tr... |
|
|
Invention
|
Compound for regulating activity of microrna-124. Disclosed in the present invention is a compoun... |
|
|
Invention
|
Heteroaromatic ring compound serving as cdk7 kinase inhibitor, preparation thereof, and use there... |
|
|
Invention
|
Pharmaceutically acceptable salt of compound and preparation method therefor. A base addition sal... |
|
2022
|
Invention
|
Novel crystal forms of peptide boric acid compound and preparation methods therefor. Disclosed ar... |
|
|
Invention
|
Compound for treating diseases related to cerebral ischemic injury.
A compound for treating dise... |
|
|
Invention
|
Compound for treating ischemic brain injury-related disease. A compound for treating an ischemic ... |
|
|
Invention
|
Pharmaceutical formulations.
Pharmaceutical formulations include N-(5-((4-(5,6-dihydro-4H-pyrrol... |
|
|
Invention
|
Pharmaceutical composition. 33)amino)ethyl)amino)phenyl)acetamide or a pharmaceutically acceptabl... |
|
2021
|
Invention
|
Heteroaromatic ring compound as ret kinase inhibitor, and preparation and use thereof.
A heteroa... |
|
|
Invention
|
Heteroaromatic ring compound as ret kinase inhibitor, and preparation and use thereof. Disclosed ... |
|
2019
|
Invention
|
Synthesis and uses of peptide borate ester compound. A peptide borate ester compound or a pharmac... |
|
2017
|
Invention
|
Deuterated 3-(4,5-substituted pyrimidinamine) phenyl derivatives and applications thereof. Disclo... |
